On September 1, 2026, Apptly Health Technologies Corp., a company listed on the Canadian Securities Exchange, announced its strategic alliance with Koning Corporation, a manufacturer known for its FDA-approved Vera Breast CT technology. This partnership aims to expand patient access to advanced non-compression 3D breast imaging, which is recognized for its capabilities in providing detailed breast scans without the discomfort typically associated with traditional mammography.
Apptly operates the UberDoc direct-pay healthcare marketplace, which positions it as a significant player in improving the healthcare experience for patients seeking innovative diagnostic solutions. The collaboration with Koning is expected to integrate their respective services to enhance availability and accessibility of non-invasive breast imaging technology, potentially making it more reachable for healthcare providers and patients alike.
The Koning Vera Breast CT is noted for its advantageous design, offering a comfortable experience while maintaining high-quality imaging. As the healthcare landscape continues to evolve, this partnership reflects a growing trend towards patient-centric solutions that focus on comfort and efficacy in medical imaging.
This development is significant in the context of healthcare advancements in Canada, particularly in breast cancer detection and management, where timely and accurate imaging is crucial for effective treatment decisions. The partnership is poised to contribute positively to the medical community by providing patients with more options in breast health screenings, further addressing gaps in existing breast imaging technologies.
Analyzed Canadian Outlets (1)
1 headline